Risk-Benefit Assessment of Concurrent Slow Dose of Mitoxantrone to Control Active Multiple Sclerosis Under Interferon Beta-1A: an Exploratory Study
AuthID
P-003-WR7
P-003-WR7
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service